HEMK2 and chronic myelogenous leukemia, BCR-ABL1 positive: We depleted N6AMT1 using CRISPR/Cas9 in human chronic myelogenous leukemia K562 cells and performed RNA sequencing (RNA-Seq) on total RNA (Fig. 1 E and F, SI Appendix, Fig. S1D, and Dataset S3).